Japanese Real-World Data Reproduce Trial Survival Signals in Lung Cancer
A Japanese historical cohort study reconstructed progression-free survival of 3.5 months in 75 atezolizumab-treated lung cancer patients from unstructured electronic ...
A Japanese historical cohort study reconstructed progression-free survival of 3.5 months in 75 atezolizumab-treated lung cancer patients from unstructured electronic ...
New findings presented at the ESMO Congress 2026 cover ctDNA monitoring in lung and breast cancer, a re-vaccination strategy for ...
A preclinical mouse study reports that the fungal-derived compound DM28 induces SLC3A2-linked ferroptosis and increases activated T cell infiltration when ...
Researchers have introduced Sapling, a computational method that summarizes the many equally plausible tumor phylogenies inferred from bulk DNA sequencing ...
A Phase 3 trial found the next-generation KRAS G12C inhibitor divarasib extended median overall survival to 17.7 months versus 12 ...
A new cell-line study reports that silencing HIF-1α with siRNA synergizes with erlotinib to suppress proliferation, invasion and glycolysis in ...
A retrospective study of 56 Chinese patients aged 60 and older found PD-1 inhibitor rechallenge after prior immunotherapy produced a ...
A narrative review argues that safety data from six phase 3 immunotherapy trials in resectable lung cancer may not transfer ...
A combined gut microbiome score linking probiotic-associated bacteria and butyrate production capacity was associated with early resistance to anti-PD-1 therapy ...
A phase 2 trial reports that camrelizumab plus famitinib produced tumor shrinkage in 42.9 percent of patients with advanced pulmonary ...
A new study reports that the m6A reader protein IGF2BP3 promotes non-small cell lung cancer progression by stabilizing TROAP mRNA ...
A case report documents curative lung resection 144 days after a patient survived grade 4 immune checkpoint inhibitor-associated myocarditis during ...
A cell-culture study reports that a mitochondria-targeting molecule, PNA-TPP, was associated with Drp1-related mitochondrial dysfunction, weakened stem-like phenotypes and an ...
A new study shows the E3 ligase UBE4B ubiquitinates and degrades VPS35, with opposing effects on cancer cell proliferation and ...
A new review maps how gut bacteria and their metabolites remotely reprogram lung tumors to shape immunotherapy response, resistance and ...
A cost-effectiveness model based on the HARMONi-6 trial finds that ivonescimab plus chemotherapy is unlikely to be cost-effective for advanced ...
A 129-patient Japanese multicenter study found that tumor PD-L1 expression did not predict the effectiveness of ALK inhibitor therapy in ...
A case report documents rapid progression and death in a lung cancer patient with a rare EGFR PACC mutation who ...
A retrospective conference study found that early consolidative cranial stereotactic radiotherapy was associated with better outcomes among selected patients with ...
Final randomized PAPILLON results found a six-month median overall-survival advantage with amivantamab plus chemotherapy in EGFR exon 20-mutated non-small cell ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.